Fifth Third Bancorp’s Abeona Therapeutics ABEO Stock Holding History

Fifth Third Bancorp’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.78K	Buy	+288	New	+$1.58K	﹤0.01%	4105
2017 Q4	–	Hold	0	–	–	–	2254
2017 Q3	–	Hold	0	–	–	–	2171
2017 Q2	–	Hold	0	–	–	–	2175
2017 Q1	–	Hold	0	–	–	–	2088

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OIA

OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fifth Third Bancorp's ABEO Position: Q2 2026 in Review

Fifth Third Bancorp opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 288 shares worth $1.78K. The stake represents ﹤0.01% of the portfolio and ranks #4105 among its holdings.

126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

Fifth Third Bancorp held 288 shares of Abeona Therapeutics worth $1.78K as of Q2 2026.
Abeona Therapeutics was a new Fifth Third Bancorp position in Q2 2026.
Abeona Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4105 holding.
126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.